Study of T- and B-cell immunity after vaccination with a virosome based influenza vaccine (Inflexal V) in patients who have undergone haematopoietic allogeneic stem cell transplantation.[ Studie av cell- och antikroppsmedierat svar efter vaccination med virosombaserat influensavaccin (Inflexal V) hos patienter som genomgått allogen stamcellstransplantation]

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2015

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza virus vaccine liposomal (Primary)
Indications Influenza virus infections
Focus Pharmacodynamics

Most Recent Events

11 Nov 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight

Ask the expert

Thank you

At a glance

Most Recent Events

You need to be a logged in or subscribed to view this content Request demo

Table of Contents

Upcoming Webinar - Rare Diseases Unraveled: Insights into Market Growth, Drug Innovation, and Industry Leaders